
Amyloidosis is a rare disease caused by the buildup of abnormal proteins called amyloid in organs and tissues. It can affect the heart, kidneys, liver, spleen, nervous system, and digestive tract. While amyloidosis is typically associated with organ damage and dysfunction, it can also lead to muscle involvement, known as amyloid myopathy. This condition causes muscle weakness and pain, as well as elevated creatine kinase levels. Although rare, amyloid myopathy is a significant manifestation of amyloidosis that can precede other organ involvement and lead to muscle wasting.
| Characteristics | Values |
|---|---|
| Definition | Amyloidosis is a rare disorder where abnormal proteins build up on organs. |
| Cause | Amyloidosis is caused by the buildup of abnormal proteins called amyloid, which is produced in the bone marrow and deposited in any tissue or organ. |
| Types | AL amyloidosis, AA amyloidosis, ATTR amyloidosis, dialysis-related amyloidosis, hereditary amyloidosis, and organ-specific amyloidosis. |
| Symptoms | Muscle weakness, enlarged tongue, skin changes, irregular heartbeat, dizziness when standing, swollen legs, weight loss, fatigue, shortness of breath, urine changes, and muscle pain. |
| Treatment | Organ transplants, chemotherapy, targeted therapies, bone marrow transplants, and stem cell transplants. |
| Prevention | Amyloidosis is not a preventable disease, but early diagnosis is crucial to prevent further protein accumulation and control symptoms. |
Explore related products
What You'll Learn

Amyloidosis is a rare disease caused by abnormal proteins
Amyloidosis is a rare disease where abnormal proteins build up in the body's organs and tissues. This build-up of amyloid proteins can lead to serious organ damage and even life-threatening organ failure if left untreated. There are several types of amyloidosis, each caused by a specific protein misfolding. These abnormal proteins can affect the heart, kidneys, liver, digestive system, nerves, and skin.
The abnormal proteins in amyloidosis are produced in the bone marrow and deposited in organs and tissues. This results in the disruption of normal organ function. For example, cardiac amyloidosis can lead to weakness, shortness of breath, fainting, and leg swelling due to heart failure. Amyloidosis can also cause an enlarged tongue, which may lead to obstructive sleep apnea, difficulty swallowing, and altered taste. Other symptoms include skin changes, such as waxy thickening, easy bruising, and purplish patches around the eyes.
The specific symptoms of amyloidosis depend on the type of protein involved and the organ system affected. For instance, AA amyloidosis is associated with long-term inflammation and can impact the kidneys, digestive organs, or heart. On the other hand, ATTR amyloidosis is caused by abnormal transthyretin protein produced by the liver, which builds up in the heart and nerves. Some forms of ATTR amyloidosis are inherited, while others develop as a person ages.
Diagnosing amyloidosis typically involves a tissue biopsy, where a sample is taken from the affected organ or areas where fibrils often collect, such as the bone marrow or fat beneath the skin. Blood and urine tests can also help detect abnormal protein levels and assess organ function. Early diagnosis is crucial to prevent further organ damage and severe complications. Treatment options include organ transplants, chemotherapy, and targeted therapies that aim to stop the production of abnormal proteins and improve symptoms.
While there is no cure for amyloidosis, early detection and treatment can help manage the condition and slow its progression. Working closely with a healthcare team is essential to reduce the risk of complications and improve outcomes for patients with this rare disease caused by abnormal proteins.
How Torn Muscles and Bruising Are Related
You may want to see also
Explore related products
$17.99

It can lead to muscle weakness and atrophy
Amyloidosis is a rare disorder that occurs when proteins in your body turn into misshapen clumps. These abnormal proteins gather on your organs, causing severe organ damage if left untreated. While amyloidosis is typically associated with organ damage, it can also lead to muscle weakness and atrophy in certain cases.
Amyloidosis can manifest in different ways, depending on the specific type and extent of protein involvement. One such manifestation is amyloid myopathy, a rare complication of systemic amyloidosis. It is characterised by proximal limb muscle weakness, elevated creatine kinase levels, and, in some cases, muscle atrophy. This condition predominantly affects the proximal muscles, such as those in the shoulders and hips, leading to weakness and potential atrophy over time.
The muscle weakness associated with amyloid myopathy can be gradual and progressive, as reported in a case of a 40-year-old female with myopathic amyloidosis. She experienced progressively worsening muscular weakness, difficulty rising from a seated posture, and proximal muscle pain. Additionally, she developed skin stiffness, tightness in the palms and soles, and muscular stiffness and pain. This case highlights the insidious nature of muscle involvement in amyloidosis, which can go unnoticed or misdiagnosed.
The underlying mechanism of muscle weakness and atrophy in amyloidosis involves the deposition of abnormal amyloid proteins in the muscles. This deposition interferes with normal muscle function, leading to weakness and, in some cases, atrophy or shrinkage of muscle fibres. The involvement of muscles in amyloidosis is well-recognised, albeit rare, and can be identified through muscle biopsy, which reveals the presence of amyloid deposits in the muscle fibres.
The treatment of amyloid myopathy aims to prevent further accumulation of abnormal proteins and manage symptoms. Early diagnosis is crucial, as it allows for the implementation of effective therapies for light chain (AL) and transthyretin (ATTR) neuropathy, which are associated with amyloidosis. Additionally, a multidisciplinary approach is often necessary to address the various aspects of the disease and its impact on muscle health.
Low-Carb Diet: Friend or Foe for Muscle Pain?
You may want to see also
Explore related products

Symptoms vary depending on the affected organ
Amyloidosis is a rare disorder where abnormal proteins build up on organs. The symptoms of amyloidosis vary depending on the affected organ. For example, cardiac amyloidosis symptoms include weakness, shortness of breath, fainting (due to abnormal heart rhythms), or leg swelling with heart failure. If amyloidosis affects the digestive system, it can impact the ability to digest food and absorb nutrients, often leading to weight loss.
AL amyloidosis, the most common type, can affect the heart, kidneys, skin, nerves, and liver. It can also cause an enlarged tongue and muscle enlargement in the shoulders. Skin changes may include a waxy thickening, easy bruising, and purplish patches around the eyes. AA amyloidosis primarily affects the kidneys but can also impact the digestive tract, liver, or heart. ATTR amyloidosis affects the liver and heart and potentially the nerves.
When amyloidosis affects the kidneys, protein can leak from the blood into the urine, causing foamy urine or reduced urination. It can also lead to swelling in the feet, ankles, and calves due to water leaking from the blood vessels. Amyloidosis affecting the heart can disturb the heart's rhythm and cause an irregular heartbeat and shortness of breath. If the nerves controlling blood pressure are impacted, dizziness or near fainting when standing may occur.
While amyloidosis can affect specific organs, it can also spread throughout the body. Localized amyloidosis usually impacts small areas of a single organ, such as the skin, bladder, or airways. Systemic amyloidosis, on the other hand, involves the buildup of fibrils on an entire organ or multiple organs. Early diagnosis and treatment are crucial to prevent further organ damage and improve symptoms.
Keto Diet: Friend or Foe for Muscle Retention?
You may want to see also
Explore related products

Treatments include chemotherapy and bone marrow transplants
Amyloidosis is a rare disorder that occurs when abnormal proteins build up in different organs of the body. It can cause muscle wasting and affect the heart, kidneys, liver, spleen, nervous system and digestive tract. While there is no cure for amyloidosis, treatments can help manage symptoms and limit amyloid protein production. Treatments include chemotherapy and bone marrow transplants, as well as targeted therapies and organ transplants.
Chemotherapy is used to eliminate microscopic remnants of damaged cells that may be circulating in the bone marrow. In AL amyloidosis, a group of plasma cells makes too many light chains, which misfold and clump together to form amyloid fibrils. These fibrils are deposited in the nerves and organs, disrupting their normal function. Chemotherapy drugs work to destroy the plasma cells that produce these abnormal proteins.
In some cases, a combination of immunotherapy, chemotherapy, and a bone marrow/stem cell transplant may be used. This involves harvesting healthy stem cells from the patient's bone marrow, freezing them, and then transplanting them back into the patient's bone marrow after chemotherapy. The transplanted stem cells can then generate new, healthy cells, essentially curing the condition.
Bone marrow transplants are not recommended for all patients, particularly those with a high bone marrow plasma cell burden. The decision to proceed with a bone marrow transplant depends on various factors, including the patient's overall health, the severity of the disease, and the potential risks and benefits of the procedure.
It is important to note that early detection and diagnosis of amyloidosis are crucial, as it can progress to life-threatening organ failure if left untreated. Treatment options should be discussed with a healthcare provider, as they can vary depending on the specific type of amyloidosis and the patient's individual symptoms.
Muscle Milk and Diarrhea: What's the Link?
You may want to see also
Explore related products

Early diagnosis is crucial for preventing further muscle damage
Amyloidosis is a rare disease caused by the buildup of abnormal proteins called amyloid in organs and tissues. While it is not preventable, early diagnosis is crucial for preventing further muscle damage and organ failure.
The abnormal proteins can gather in a small area on a single organ (localized amyloidosis) or spread throughout the body (systemic amyloidosis). Localized amyloidosis usually affects the skin, bladder, or airways, while systemic amyloidosis can impact multiple organ systems, including the heart, kidneys, liver, spleen, nervous system, and digestive tract.
The symptoms of amyloidosis vary depending on the specific organs and tissues involved. Some common symptoms include an enlarged tongue, skin changes, irregular heartbeat, dizziness when standing, swollen legs, unintentional weight loss, severe fatigue, and shortness of breath. In rare cases, amyloidosis can also cause muscle weakness, known as amyloid myopathy, which can lead to difficulty in performing everyday tasks.
The early diagnosis of amyloidosis is essential because treatment options can prevent further protein accumulation and control the symptoms. Healthcare providers can stop the production of abnormal proteins and slow down the progression of the disease. Treatment options include organ transplants, chemotherapy, or targeted therapies. A bone marrow transplant, for example, uses healthy stem cells from the patient's body to replace unhealthy cells destroyed by chemotherapy.
Therefore, it is important to consult a healthcare provider if any signs or symptoms of amyloidosis are present. Early diagnosis and treatment can help prevent further muscle damage and potential organ failure caused by protein buildup.
Quicksand: A Sticky Situation for Your Muscles
You may want to see also
Frequently asked questions
Amyloidosis is a rare disease caused by the buildup of abnormal proteins called amyloid in organs and tissues.
Amyloidosis can cause muscle wasting, or myopathy, as a rare manifestation of the disease. This can lead to proximal limb muscle weakness and elevated creatine kinase serum levels. Myopathy is often misdiagnosed or missed due to overlapping symptoms with other inflammatory myopathies.
The symptoms of amyloidosis vary depending on the specific type and the organs affected. Some common symptoms include unintentional weight loss, severe fatigue, shortness of breath, an enlarged tongue, skin changes, irregular heartbeat, and dizziness when standing.











































